Abiopharma

New Form 8-K - Envista Holdings Corp Filed: 2025-07-31 AccNo: 0001757073-25-000042 Size: 720 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Safety Shot, Inc. Filed: 2025-07-31 AccNo: 0001641172-25-021736 Size: 270 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - ILLUMINA, INC. Filed: 2025-07-31 AccNo: 0001110803-25-000057 Size: 841 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 424B5 - Lyell Immunopharma, Inc. Filed: 2025-07-31 AccNo: 0001193125-25-170528 Size: 457 KB

iRhythm Technologies, Inc. - iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions

New Form 4 - AVADEL PHARMACEUTICALS PLC Filed: 2025-07-31 AccNo: 0001104659-25-072692 Size: 7 KB

New Form 8-K - iRhythm Technologies, Inc. Filed: 2025-07-31 AccNo: 0001388658-25-000194 Size: 515 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions

New Form 4 - AVADEL PHARMACEUTICALS PLC Filed: 2025-07-31 AccNo: 0001104659-25-072686 Size: 9 KB

New Form 4 - AVADEL PHARMACEUTICALS PLC Filed: 2025-07-31 AccNo: 0001104659-25-072685 Size: 7 KB

New Form 8-K - CORCEPT THERAPEUTICS INC Filed: 2025-07-31 AccNo: 0001628280-25-036999 Size: 229 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure

New Form 8-K - OPKO HEALTH, INC. Filed: 2025-07-31 AccNo: 0000950170-25-100891 Size: 452 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 4 - AVADEL PHARMACEUTICALS PLC Filed: 2025-07-31 AccNo: 0001104659-25-072682 Size: 7 KB

iRhythm Technologies, Inc. - iRhythm Technologies Announces Second Quarter 2025 Financial Results

Ultragenyx Completes Enrollment of Phase 3 Aspire Study Evaluating GTX-102 for the Treatment of Angelman Syndrome